Lantheus Announces Top Rated Oral Presentation Featuring PYLARIFY AI™ at the 2023 European Association of Nuclear Medicine (EANM) Annual Meeting
September 01, 2023 08:30 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and...
Lantheus to Present at the Wells Fargo Healthcare Conference
August 31, 2023 08:00 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and...
Lantheus Announces Agreement to Sell RELISTOR® Royalties to HealthCare Royalty
August 03, 2023 07:10 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics,...
Lantheus Reports Second Quarter 2023 Financial Results
August 03, 2023 07:00 ET
|
Lantheus Holdings, Inc.
Worldwide revenue of $321.7 million for the second quarter 2023, representing an increase of 43.8% from the prior year periodGAAP net income of $94.1 million for the second quarter 2023, compared to...
Lantheus to Host Second Quarter 2023 Earnings Conference Call and Webcast on August 3, 2023, at 8:00 a.m. Eastern Time
July 20, 2023 08:30 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday,...
Lantheus Announces Presentations Featuring PYLARIFY AI™ at the 2023 Society for Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
June 12, 2023 08:30 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and...
Lantheus to Present at the Jefferies Healthcare Conference
June 01, 2023 08:30 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and...
Lantheus Announces Payment to Contingent Value Rights (CVR) Holders of $99.7 million or $1.15 per CVR
May 23, 2023 08:30 ET
|
Lantheus Holdings, Inc.
BEDFORD, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and...
Lantheus Reports First Quarter 2023 Financial Results
May 04, 2023 07:00 ET
|
Lantheus Holdings, Inc.
Worldwide revenue of $300.8 million for the first quarter 2023, representing an increase of 44.0% from the prior year periodGAAP net loss of $2.8 million for the first quarter 2023, compared to GAAP...
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
April 24, 2023 07:30 ET
|
Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics,...